Synergistic defects of different molecules in the cytotoxic pathway lead to clinical familial hemophagocytic lymphohistiocytosis.

MLA

Zhang, Kejian, et al. “Synergistic Defects of Different Molecules in the Cytotoxic Pathway Lead to Clinical Familial Hemophagocytic Lymphohistiocytosis.” Blood, vol. 124, no. 8, Aug. 2014, pp. 1331–34. EBSCOhost, https://doi.org/10.1182/blood-2014-05-573105.

APA

Zhang, K., Chandrakasan, S., Chapman, H., Valencia, C. A., Husami, A., Kissell, D., Johnson, J. A., & Filipovich, A. H. (2014). Synergistic defects of different molecules in the cytotoxic pathway lead to clinical familial hemophagocytic lymphohistiocytosis. Blood, 124(8), 1331–1334. https://doi.org/10.1182/blood-2014-05-573105

Chicago

Zhang, Kejian, Shanmuganathan Chandrakasan, Heather Chapman, C Alexander Valencia, Ammar Husami, Diane Kissell, Judith A Johnson, and Alexandra H Filipovich. 2014. “Synergistic Defects of Different Molecules in the Cytotoxic Pathway Lead to Clinical Familial Hemophagocytic Lymphohistiocytosis.” Blood 124 (8): 1331–34. doi:10.1182/blood-2014-05-573105.